自身免疫性炎性肌病亚型的甲襞视频毛细血管镜异常
研究基于加拿大炎性肌病研究前瞻性队列99例自身免疫性炎性肌病患者,采用甲襞视频毛细血管镜(NVC)评估毛细血管密度及形态学异常。结果显示皮肌炎、硬化性肌炎和抗合成酶综合征常见NVC异常,而免疫介导坏死性肌病、包涵体肌炎和多发性肌炎未见NVC异常。NVC模式在皮肌炎、硬化性肌炎和抗合成酶综合征之间无鉴别意义。
要点
- 皮肌炎、硬化性肌炎和抗合成酶综合征中毛细血管密度降低最常见(分别为95%、92%、87%)。
- 44%受试者存在异常NVC,25%为非特异性异常,30%为正常NVC。
- NVC模式不能鉴别皮肌炎、硬化性肌炎和抗合成酶综合征,但可能有助于区分这三类与免疫介导坏死性肌病、包涵体肌炎和多发性肌炎。
核心结论
- 皮肌炎、硬化性肌炎和抗合成酶综合征常见NVC异常,但NVC模式与特定亚型无关联。
- NVC可能有助于区分皮肌炎、硬化性肌炎和抗合成酶综合征与免疫介导坏死性肌病、包涵体肌炎和多发性肌炎。
研究设计与样本
- 研究纳入加拿大炎性肌病研究(CIMS)前瞻性队列中的99例自身免疫性炎性肌病患者。
- 使用DS MEDICA Videocap(×200放大)采集NVC图像,定量和半定量评估毛细血管密度,并按标准化半定量量表(0=无,1=≤33%,2=33-66%,3=≥66%异常毛细血管/总毛细血管每毫米)评估扩张、巨大毛细血管、分支毛细血管和微出血。
- 描述NVC模式(即硬皮病早期/活动期/晚期、硬皮病样、非特异性和正常),并比较不同亚型间的NVC特征和模式。
主要发现
- 99例受试者中,皮肌炎41例、硬化性肌炎24例、抗合成酶综合征16例、免疫介导坏死性肌病7例、包涵体肌炎8例、多发性肌炎3例;71%为女性,中位病程1年(IQR 0.4-2.8)。
- 毛细血管密度降低在皮肌炎中占95%、硬化性肌炎中占92%、抗合成酶综合征中占87%。
- 44%受试者存在异常NVC,25%为非特异性NVC异常,30%为正常NVC。
- NVC模式在皮肌炎、硬化性肌炎和抗合成酶综合征之间无鉴别意义。
- 免疫介导坏死性肌病、包涵体肌炎和多发性肌炎中未见NVC异常。
关键数值与推荐
- 毛细血管密度降低比例:皮肌炎95%、硬化性肌炎92%、抗合成酶综合征87%。
- NVC异常总体分布:44%异常、25%非特异性异常、30%正常。
临床怎么用
- 在自身免疫性炎性肌病中,NVC可用于识别皮肌炎、硬化性肌炎和抗合成酶综合征中常见的毛细血管密度降低等异常。
- NVC模式不能用于区分皮肌炎、硬化性肌炎和抗合成酶综合征,但可能有助于将这些亚型与免疫介导坏死性肌病、包涵体肌炎和多发性肌炎区分。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Nailfold videocapillaroscopy (NVC) alterations have been described in autoimmune inflammatory myopathies (AIM). This study aimed to describe NVC abnormalities in AIM subsets using a clinico-sero-pathological approach. METHODS: We studied subjects from the Canadian Inflammatory Myopathy Study (CIMS), a prospective AIM cohort. NVC images were acquired using the DS MEDICA Videocap (×200 magnification). Capillary density was scored quantitatively and semi-quantitatively. Ectasias, giant capillaries, ramified capillaries and microhaemorrhages were scored as present or absent and with a standardized semi-quantitative scale (0 = none, 1=≤33%, 2 = 33-66% and 3=≥66% abnormal capillaries/total capillaries per mm). NVC patterns (i.e. scleroderma early/active/late, scleroderma-like, non-specific and normal) were described. NVC features and patterns were compared between AIM subsets. RESULTS: We included 99 AIM subjects: 41 dermatomyositis, 24 scleromyositis, 16 anti-synthetase syndrome, seven immune-mediated necrotizing myopathy, eight inclusion body myositis and three polymyositis. A total of 71% were female, and the median disease duration was 1 year [IQR; 0.4-2.8]. The most frequent NVC abnormality was decreased capillary density in dermatomyositis (95%), scleromyositis (92%) and anti-synthetase syndrome (87%). Qualitatively, 44% of subjects had abnormal NVC, 25% non-specific NVC abnormalities and 30% normal NVC. NVC patterns were not discriminant between dermatomyositis, scleromyositis and anti-synthetase syndrome. NVC abnormalities were absent in immune-mediated necrotizing myopathy, inclusion body myositis and polymyositis. CONCLUSION: Dermatomyositis, scleromyositis and anti-synthetase syndrome showed frequent NVC abnormalities, although no NVC pattern was associated with a particular subset in our study. However, NVC may help distinguish between these subsets and immune-mediated necrotizing myopathy, inclusion body myositis and polymyositis.
引用
- Leclair V, Cotton T, Shen HC, et al. Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets. Rheumatology (Oxford). 2026. PMID: 41206056. doi:10.1093/rheumatology/keaf594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。